

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.30067024 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.44863551 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.44863551 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.44863551 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.44863551 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.44863551 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.44863551 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.28101533 |
| 9 | respiratory burst (GO:0045730) | 5.23510399 |
| 10 | response to peptidoglycan (GO:0032494) | 5.07553026 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.58472428 |
| 12 | superoxide anion generation (GO:0042554) | 4.52909225 |
| 13 | neutrophil activation (GO:0042119) | 4.43518739 |
| 14 | positive regulation of mast cell activation (GO:0033005) | 4.34604423 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33641060 |
| 16 | granulocyte activation (GO:0036230) | 4.30134428 |
| 17 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.25969037 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 4.22602182 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.16992220 |
| 20 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.14412065 |
| 21 | neutrophil mediated immunity (GO:0002446) | 4.11830339 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.11496473 |
| 23 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.10744440 |
| 24 | positive regulation of mast cell degranulation (GO:0043306) | 4.10744440 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.04570772 |
| 26 | cellular response to exogenous dsRNA (GO:0071360) | 4.04213020 |
| 27 | regulation of mast cell degranulation (GO:0043304) | 3.99070372 |
| 28 | cellular response to interferon-beta (GO:0035458) | 3.93879564 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.93543014 |
| 30 | response to host immune response (GO:0052572) | 3.89651559 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.89651559 |
| 32 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.86284803 |
| 33 | reactive oxygen species biosynthetic process (GO:1903409) | 3.85744536 |
| 34 | leukocyte aggregation (GO:0070486) | 3.83485977 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83035063 |
| 36 | negative regulation of cell killing (GO:0031342) | 3.83035063 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.82017677 |
| 38 | microglial cell activation (GO:0001774) | 3.73475708 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.72025647 |
| 40 | * myeloid cell activation involved in immune response (GO:0002275) | 3.68255393 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.65585870 |
| 42 | * regulation of mast cell activation (GO:0033003) | 3.62700454 |
| 43 | leukocyte mediated cytotoxicity (GO:0001909) | 3.61413728 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.60053501 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.60053501 |
| 46 | negative regulation of growth of symbiont in host (GO:0044130) | 3.58351068 |
| 47 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.58351068 |
| 48 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.58351068 |
| 49 | regulation of growth of symbiont in host (GO:0044126) | 3.58351068 |
| 50 | response to interferon-beta (GO:0035456) | 3.56460727 |
| 51 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.54198507 |
| 52 | response to type I interferon (GO:0034340) | 3.53306551 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.51449961 |
| 54 | defense response to protozoan (GO:0042832) | 3.47851201 |
| 55 | macrophage activation (GO:0042116) | 3.44121291 |
| 56 | * mast cell activation (GO:0045576) | 3.42584438 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 3.39950041 |
| 58 | B cell mediated immunity (GO:0019724) | 3.39429245 |
| 59 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.36834929 |
| 60 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.35676358 |
| 61 | response to host (GO:0075136) | 3.35264923 |
| 62 | response to host defenses (GO:0052200) | 3.35264923 |
| 63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35264923 |
| 64 | regulation of chemokine biosynthetic process (GO:0045073) | 3.32826824 |
| 65 | T cell migration (GO:0072678) | 3.28317713 |
| 66 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.22410676 |
| 67 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.22165747 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.22006413 |
| 69 | response to interferon-alpha (GO:0035455) | 3.21425593 |
| 70 | cellular response to zinc ion (GO:0071294) | 3.19829052 |
| 71 | negative regulation of viral genome replication (GO:0045071) | 3.17283780 |
| 72 | cellular extravasation (GO:0045123) | 3.16257488 |
| 73 | positive regulation of lymphocyte migration (GO:2000403) | 3.15418562 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15288313 |
| 75 | myeloid leukocyte mediated immunity (GO:0002444) | 3.13874806 |
| 76 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.10527995 |
| 77 | response to protozoan (GO:0001562) | 3.09860219 |
| 78 | detection of other organism (GO:0098543) | 3.09424593 |
| 79 | DNA deamination (GO:0045006) | 3.08496476 |
| 80 | regulation of hypersensitivity (GO:0002883) | 3.07615952 |
| 81 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07096479 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06853782 |
| 83 | positive regulation of T cell migration (GO:2000406) | 3.06817965 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03852082 |
| 85 | * myeloid leukocyte activation (GO:0002274) | 3.03802905 |
| 86 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.03549119 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03544144 |
| 88 | lymphocyte chemotaxis (GO:0048247) | 3.01104188 |
| 89 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.00609926 |
| 90 | regulation of leukocyte degranulation (GO:0043300) | 3.00389089 |
| 91 | regulation of B cell differentiation (GO:0045577) | 2.99223205 |
| 92 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98572097 |
| 93 | positive regulation of interferon-beta production (GO:0032728) | 2.98327908 |
| 94 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.94799659 |
| 95 | natural killer cell mediated immunity (GO:0002228) | 2.94799659 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.93475098 |
| 97 | lipoxygenase pathway (GO:0019372) | 2.93183956 |
| 98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92378755 |
| 99 | interferon-gamma production (GO:0032609) | 2.91336499 |
| 100 | negative regulation of interleukin-1 production (GO:0032692) | 2.91112015 |
| 101 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.90045565 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.89813950 |
| 103 | detection of bacterium (GO:0016045) | 2.89632172 |
| 104 | regulation of lymphocyte migration (GO:2000401) | 2.86724605 |
| 105 | monocyte chemotaxis (GO:0002548) | 2.86555990 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86532288 |
| 107 | * leukocyte degranulation (GO:0043299) | 2.85093266 |
| 108 | positive regulation of defense response to virus by host (GO:0002230) | 2.84313691 |
| 109 | regulation of T cell migration (GO:2000404) | 2.83872610 |
| 110 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.83690393 |
| 111 | detection of external biotic stimulus (GO:0098581) | 2.83176052 |
| 112 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82371432 |
| 113 | T-helper 1 type immune response (GO:0042088) | 2.81415155 |
| 114 | leukotriene metabolic process (GO:0006691) | 2.81189124 |
| 115 | phagosome maturation (GO:0090382) | 2.79589772 |
| 116 | B cell receptor signaling pathway (GO:0050853) | 2.78668629 |
| 117 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78048826 |
| 118 | adaptation of signaling pathway (GO:0023058) | 2.77128096 |
| 119 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.74129621 |
| 120 | regulation of germinal center formation (GO:0002634) | 2.73599956 |
| 121 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.72592371 |
| 122 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.71769416 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70808871 |
| 124 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68037050 |
| 125 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.68029000 |
| 126 | regulation of interleukin-12 production (GO:0032655) | 2.67980819 |
| 127 | tryptophan catabolic process (GO:0006569) | 2.67341783 |
| 128 | indole-containing compound catabolic process (GO:0042436) | 2.67341783 |
| 129 | indolalkylamine catabolic process (GO:0046218) | 2.67341783 |
| 130 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.66207163 |
| 131 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.63174312 |
| 132 | detection of biotic stimulus (GO:0009595) | 2.62097603 |
| 133 | positive regulation of leukocyte degranulation (GO:0043302) | 2.59414686 |
| 134 | platelet dense granule organization (GO:0060155) | 2.58701589 |
| 135 | negative regulation of interleukin-6 production (GO:0032715) | 2.57903005 |
| 136 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.56016268 |
| 137 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.55533502 |
| 138 | regulation of T-helper 1 type immune response (GO:0002825) | 2.54645683 |
| 139 | regulation of memory T cell differentiation (GO:0043380) | 2.53678945 |
| 140 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.51922132 |
| 141 | positive regulation of type 2 immune response (GO:0002830) | 2.49559335 |
| 142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.48167310 |
| 143 | purinergic receptor signaling pathway (GO:0035587) | 2.47660791 |
| 144 | cellular response to interferon-gamma (GO:0071346) | 2.46156082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.82992462 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.63889571 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.39954437 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.42422211 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.31621877 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.10894905 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72430845 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.70423905 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.49160157 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41473515 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22533601 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.21645207 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02168921 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.85166703 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74141940 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64548397 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56699036 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.52871521 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.52732842 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32169709 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22251194 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06302087 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.03663214 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.01607560 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95959846 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92585225 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92171493 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91644941 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90772195 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80096309 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78741206 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.73414303 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71351765 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.68205766 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63323053 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63036032 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62925447 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62069339 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60735707 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55441083 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52247539 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49132216 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47346101 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45835977 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44858900 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44681143 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42731245 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39250995 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38318455 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36090256 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34140744 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33266190 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33038637 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32686736 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32684674 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.29621156 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27906084 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27865181 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26299066 |
| 60 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.24887643 |
| 61 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24599404 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23286615 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21044173 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19693584 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18825728 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18119238 |
| 67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.18005575 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16018279 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14856029 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14664496 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.14610540 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14128326 |
| 73 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.13681497 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13519596 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13327513 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13292982 |
| 77 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13222945 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11228699 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11039619 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09114616 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09059638 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08939994 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08652086 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08645496 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07789539 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07563062 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07296615 |
| 88 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06282916 |
| 89 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04333614 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01357936 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01348466 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01268149 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00901576 |
| 94 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00694330 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00694330 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00156931 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99902401 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99902401 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99337734 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97610855 |
| 101 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96644084 |
| 102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.96496446 |
| 103 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96470911 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94618821 |
| 105 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93782302 |
| 106 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93350572 |
| 107 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.91570089 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89824129 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89616531 |
| 110 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89286348 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89083273 |
| 112 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88413535 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88119574 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.88017026 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87879313 |
| 116 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87654319 |
| 117 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87391459 |
| 118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86848698 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86193800 |
| 120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86080237 |
| 121 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.84903563 |
| 122 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.84561284 |
| 123 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.83840432 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83276840 |
| 125 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.82165199 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81271003 |
| 127 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.81052635 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79852372 |
| 129 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.78141865 |
| 130 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77980587 |
| 131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77829386 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75909394 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 0.75826191 |
| 134 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75587235 |
| 135 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.75112330 |
| 136 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73795252 |
| 137 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.72767277 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71464243 |
| 139 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.70079264 |
| 140 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.69817051 |
| 141 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69746321 |
| 142 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.69037363 |
| 143 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.68347420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.90867869 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.03824983 |
| 3 | MP0009785_altered_susceptibility_to | 3.94593115 |
| 4 | MP0003436_decreased_susceptibility_to | 3.89033266 |
| 5 | MP0002419_abnormal_innate_immunity | 3.46764069 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.32497206 |
| 7 | MP0003724_increased_susceptibility_to | 3.25403363 |
| 8 | MP0005025_abnormal_response_to | 3.19347544 |
| 9 | MP0005671_abnormal_response_to | 2.74726836 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.72464801 |
| 11 | MP0001790_abnormal_immune_system | 2.70889565 |
| 12 | MP0005387_immune_system_phenotype | 2.70889565 |
| 13 | MP0006082_CNS_inflammation | 2.65059789 |
| 14 | MP0003303_peritoneal_inflammation | 2.64996246 |
| 15 | MP0002723_abnormal_immune_serum | 2.60204932 |
| 16 | MP0001800_abnormal_humoral_immune | 2.52627850 |
| 17 | MP0001819_abnormal_immune_cell | 2.42896047 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.41587617 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.24409454 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.13655557 |
| 21 | MP0000685_abnormal_immune_system | 2.12972099 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.09035725 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.02747712 |
| 24 | MP0002405_respiratory_system_inflammati | 1.94620413 |
| 25 | MP0005174_abnormal_tail_pigmentation | 1.92521031 |
| 26 | MP0002006_tumorigenesis | 1.90619786 |
| 27 | MP0000343_altered_response_to | 1.87331021 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.84134972 |
| 29 | MP0009764_decreased_sensitivity_to | 1.82265419 |
| 30 | MP0000015_abnormal_ear_pigmentation | 1.79118732 |
| 31 | MP0000716_abnormal_immune_system | 1.75309941 |
| 32 | MP0001853_heart_inflammation | 1.73377341 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.71536820 |
| 34 | MP0002398_abnormal_bone_marrow | 1.66219332 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 1.64626927 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.63287684 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.59178323 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.58552983 |
| 39 | MP0000858_altered_metastatic_potential | 1.56169122 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.55291803 |
| 41 | MP0008469_abnormal_protein_level | 1.54858495 |
| 42 | MP0003448_altered_tumor_morphology | 1.51327716 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.49661663 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.44407672 |
| 45 | MP0002429_abnormal_blood_cell | 1.42948956 |
| 46 | MP0003075_altered_response_to | 1.42701168 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.42277744 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.41319870 |
| 49 | MP0009278_abnormal_bone_marrow | 1.40882324 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.35633916 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.35633916 |
| 52 | MP0008057_abnormal_DNA_replication | 1.33238851 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.32340179 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.29177798 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.28940377 |
| 56 | MP0002722_abnormal_immune_system | 1.28650109 |
| 57 | MP0004510_myositis | 1.28341154 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26803958 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.25357765 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.23630625 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.21970785 |
| 62 | MP0004947_skin_inflammation | 1.19339383 |
| 63 | MP0003690_abnormal_glial_cell | 1.16738343 |
| 64 | MP0005310_abnormal_salivary_gland | 1.13885347 |
| 65 | MP0005164_abnormal_response_to | 1.10346662 |
| 66 | MP0009840_abnormal_foam_cell | 1.07277685 |
| 67 | MP0005166_decreased_susceptibility_to | 1.05774992 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.04604780 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.03790013 |
| 70 | MP0003186_abnormal_redox_activity | 1.03548593 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 1.02373056 |
| 72 | MP0002254_reproductive_system_inflammat | 1.00915973 |
| 73 | MP0003136_yellow_coat_color | 0.98936886 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.98317030 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.97329015 |
| 76 | MP0000490_abnormal_crypts_of | 0.97281548 |
| 77 | MP0003300_gastrointestinal_ulcer | 0.96374466 |
| 78 | MP0010307_abnormal_tumor_latency | 0.94914757 |
| 79 | MP0005390_skeleton_phenotype | 0.94652666 |
| 80 | MP0004381_abnormal_hair_follicle | 0.92577521 |
| 81 | MP0000920_abnormal_myelination | 0.90907134 |
| 82 | MP0002933_joint_inflammation | 0.90083406 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.89992258 |
| 84 | MP0009763_increased_sensitivity_to | 0.88889201 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 0.87648526 |
| 86 | MP0000604_amyloidosis | 0.86541601 |
| 87 | MP0003646_muscle_fatigue | 0.85708099 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.83736963 |
| 89 | MP0008058_abnormal_DNA_repair | 0.83131345 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.82573363 |
| 91 | MP0005409_darkened_coat_color | 0.81935704 |
| 92 | MP0008872_abnormal_physiological_respon | 0.81052136 |
| 93 | MP0006054_spinal_hemorrhage | 0.80729683 |
| 94 | MP0008260_abnormal_autophagy | 0.80103459 |
| 95 | MP0005171_absent_coat_pigmentation | 0.79452854 |
| 96 | MP0004147_increased_porphyrin_level | 0.78801342 |
| 97 | MP0003828_pulmonary_edema | 0.78790215 |
| 98 | MP0004142_abnormal_muscle_tone | 0.78064596 |
| 99 | MP0003011_delayed_dark_adaptation | 0.77167885 |
| 100 | MP0001851_eye_inflammation | 0.77017327 |
| 101 | MP0003693_abnormal_embryo_hatching | 0.76682854 |
| 102 | MP0001663_abnormal_digestive_system | 0.73482997 |
| 103 | MP0005551_abnormal_eye_electrophysiolog | 0.72178301 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.70847488 |
| 105 | MP0000703_abnormal_thymus_morphology | 0.70011622 |
| 106 | MP0003195_calcinosis | 0.69615160 |
| 107 | MP0010094_abnormal_chromosome_stability | 0.68512593 |
| 108 | MP0002132_abnormal_respiratory_system | 0.68389054 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.68375627 |
| 110 | MP0003866_abnormal_defecation | 0.68170062 |
| 111 | MP0001542_abnormal_bone_strength | 0.67705594 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.66677444 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.66550552 |
| 114 | MP0001764_abnormal_homeostasis | 0.66547345 |
| 115 | MP0002653_abnormal_ependyma_morphology | 0.66009546 |
| 116 | MP0000371_diluted_coat_color | 0.65556603 |
| 117 | MP0004883_abnormal_blood_vessel | 0.64960424 |
| 118 | MP0003795_abnormal_bone_structure | 0.64154845 |
| 119 | MP0000249_abnormal_blood_vessel | 0.62844950 |
| 120 | MP0005365_abnormal_bile_salt | 0.62150483 |
| 121 | MP0002019_abnormal_tumor_incidence | 0.61390176 |
| 122 | MP0005253_abnormal_eye_physiology | 0.60848459 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.58984506 |
| 124 | MP0001186_pigmentation_phenotype | 0.56118254 |
| 125 | MP0001873_stomach_inflammation | 0.54160126 |
| 126 | MP0008007_abnormal_cellular_replicative | 0.54146143 |
| 127 | MP0008873_increased_physiological_sensi | 0.53920782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.41334229 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.74214937 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.23442667 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.95490503 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.92653791 |
| 6 | Chronic obstructive pulmonary disease (HP:0006510) | 4.57166911 |
| 7 | Obstructive lung disease (HP:0006536) | 4.57166911 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.41388388 |
| 9 | Myositis (HP:0100614) | 4.40119710 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.33656983 |
| 11 | Recurrent skin infections (HP:0001581) | 4.17853478 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.87945321 |
| 13 | Gingivitis (HP:0000230) | 3.78607217 |
| 14 | Prostate neoplasm (HP:0100787) | 3.73895843 |
| 15 | Stomatitis (HP:0010280) | 3.62538490 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.51664782 |
| 17 | Optic neuritis (HP:0100653) | 3.51664782 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.51446507 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.50013000 |
| 20 | Orchitis (HP:0100796) | 3.45574067 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.35687382 |
| 22 | Basal ganglia calcification (HP:0002135) | 3.27992346 |
| 23 | Abnormality of the prostate (HP:0008775) | 3.23988891 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.17049514 |
| 25 | Petechiae (HP:0000967) | 3.16266194 |
| 26 | Recurrent viral infections (HP:0004429) | 3.16053903 |
| 27 | Meningitis (HP:0001287) | 3.15754800 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.14341635 |
| 29 | Agnosia (HP:0010524) | 3.14165490 |
| 30 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.13319408 |
| 31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.10179997 |
| 32 | Vasculitis (HP:0002633) | 3.08454302 |
| 33 | Chromsome breakage (HP:0040012) | 3.07435124 |
| 34 | Periodontitis (HP:0000704) | 3.05805646 |
| 35 | Recurrent pneumonia (HP:0006532) | 3.00513438 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.00369282 |
| 37 | Increased IgM level (HP:0003496) | 2.96046459 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.85395663 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85210505 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85210505 |
| 41 | Congenital stationary night blindness (HP:0007642) | 2.80838882 |
| 42 | Thrombocytosis (HP:0001894) | 2.79313656 |
| 43 | Chronic otitis media (HP:0000389) | 2.77397379 |
| 44 | Cellulitis (HP:0100658) | 2.75958439 |
| 45 | T lymphocytopenia (HP:0005403) | 2.74241036 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.72326800 |
| 47 | Axonal loss (HP:0003447) | 2.71177240 |
| 48 | B lymphocytopenia (HP:0010976) | 2.70366809 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.70280775 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.70280775 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.70280775 |
| 52 | Disinhibition (HP:0000734) | 2.66568667 |
| 53 | Eosinophilia (HP:0001880) | 2.66323897 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.65726923 |
| 55 | Pustule (HP:0200039) | 2.64039105 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.61243869 |
| 57 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59760929 |
| 58 | Poor head control (HP:0002421) | 2.57911931 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.56764522 |
| 60 | Recurrent lower respiratory tract infections (HP:0002783) | 2.55646857 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.54732196 |
| 62 | Urticaria (HP:0001025) | 2.53027545 |
| 63 | Leukocytosis (HP:0001974) | 2.52092232 |
| 64 | Thick nail (HP:0001805) | 2.43458607 |
| 65 | Papilledema (HP:0001085) | 2.41422427 |
| 66 | Granulocytopenia (HP:0001913) | 2.41403213 |
| 67 | IgM deficiency (HP:0002850) | 2.40588356 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.40238639 |
| 69 | Osteomyelitis (HP:0002754) | 2.39719046 |
| 70 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.36664392 |
| 71 | Mutism (HP:0002300) | 2.34196684 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.29463364 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.28148656 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.27611994 |
| 75 | J-shaped sella turcica (HP:0002680) | 2.27387222 |
| 76 | Stomach cancer (HP:0012126) | 2.27152996 |
| 77 | Pancreatic cysts (HP:0001737) | 2.26532245 |
| 78 | Joint hemorrhage (HP:0005261) | 2.24197150 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.22271398 |
| 80 | Molar tooth sign on MRI (HP:0002419) | 2.20384392 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 2.20384392 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.20284278 |
| 83 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18292014 |
| 84 | Hemoptysis (HP:0002105) | 2.18093998 |
| 85 | Thyroiditis (HP:0100646) | 2.17378860 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.16970945 |
| 87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16825809 |
| 88 | Loss of speech (HP:0002371) | 2.16819599 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.15865192 |
| 90 | Anorexia (HP:0002039) | 2.12450222 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.12249309 |
| 92 | Polyneuropathy (HP:0001271) | 2.11207253 |
| 93 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10327991 |
| 94 | Clubbing of toes (HP:0100760) | 2.09976036 |
| 95 | Sepsis (HP:0100806) | 2.09845585 |
| 96 | Attenuation of retinal blood vessels (HP:0007843) | 2.09052511 |
| 97 | Hematochezia (HP:0002573) | 2.07239163 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.05284440 |
| 99 | Abnormality of T cells (HP:0002843) | 2.04623444 |
| 100 | Agitation (HP:0000713) | 2.03781884 |
| 101 | Glomerulonephritis (HP:0000099) | 2.03043796 |
| 102 | Albinism (HP:0001022) | 2.00156739 |
| 103 | Hyperalaninemia (HP:0003348) | 1.98161543 |
| 104 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98161543 |
| 105 | Abnormality of alanine metabolism (HP:0010916) | 1.98161543 |
| 106 | Encephalitis (HP:0002383) | 1.98058635 |
| 107 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96083865 |
| 108 | Hypoproteinemia (HP:0003075) | 1.96019437 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95718032 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95485165 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95485165 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95485165 |
| 113 | Increased serum ferritin (HP:0003281) | 1.95114143 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 1.91774694 |
| 115 | Gingival bleeding (HP:0000225) | 1.90765683 |
| 116 | Episodic fever (HP:0001954) | 1.89901032 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 1.89094782 |
| 118 | Type I transferrin isoform profile (HP:0003642) | 1.88875456 |
| 119 | Amyloidosis (HP:0011034) | 1.88816780 |
| 120 | Severe combined immunodeficiency (HP:0004430) | 1.88394842 |
| 121 | IgG deficiency (HP:0004315) | 1.87924987 |
| 122 | Skin ulcer (HP:0200042) | 1.85758232 |
| 123 | Purpura (HP:0000979) | 1.83723342 |
| 124 | Duplicated collecting system (HP:0000081) | 1.82327462 |
| 125 | Arterial thrombosis (HP:0004420) | 1.82265056 |
| 126 | Pathologic fracture (HP:0002756) | 1.81736444 |
| 127 | Gangrene (HP:0100758) | 1.81481813 |
| 128 | Global brain atrophy (HP:0002283) | 1.81040058 |
| 129 | Epistaxis (HP:0000421) | 1.80503961 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.79769233 |
| 131 | Abnormality of male internal genitalia (HP:0000022) | 1.79490854 |
| 132 | Constricted visual fields (HP:0001133) | 1.78768618 |
| 133 | Agammaglobulinemia (HP:0004432) | 1.78588705 |
| 134 | Prolonged bleeding time (HP:0003010) | 1.77043683 |
| 135 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77024077 |
| 136 | Pancreatic fibrosis (HP:0100732) | 1.76680234 |
| 137 | Chronic diarrhea (HP:0002028) | 1.76377206 |
| 138 | Lymphopenia (HP:0001888) | 1.76126925 |
| 139 | Pulmonary embolism (HP:0002204) | 1.76063263 |
| 140 | Cheilitis (HP:0100825) | 1.75746303 |
| 141 | Chest pain (HP:0100749) | 1.74436484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.27894272 |
| 2 | BLK | 3.97852099 |
| 3 | MAP3K14 | 3.81239899 |
| 4 | RIPK4 | 3.20821276 |
| 5 | KIT | 2.88728832 |
| 6 | IRAK3 | 2.75002159 |
| 7 | TXK | 2.61350677 |
| 8 | PBK | 2.60354821 |
| 9 | TEC | 2.57616863 |
| 10 | FRK | 2.51410649 |
| 11 | PIM2 | 2.37296808 |
| 12 | TBK1 | 2.36085866 |
| 13 | MAP4K1 | 2.23698211 |
| 14 | TYK2 | 2.14791310 |
| 15 | IKBKE | 2.01113377 |
| 16 | CLK1 | 2.00230853 |
| 17 | BTK | 1.87666588 |
| 18 | STK16 | 1.86279720 |
| 19 | IKBKB | 1.73149193 |
| 20 | ACVR1B | 1.66534127 |
| 21 | SYK | 1.63881818 |
| 22 | ZAP70 | 1.55196047 |
| 23 | TAOK3 | 1.52723653 |
| 24 | LYN | 1.52631504 |
| 25 | MAP4K2 | 1.51503042 |
| 26 | JAK3 | 1.46370604 |
| 27 | CSK | 1.45583717 |
| 28 | CAMKK2 | 1.41861529 |
| 29 | EIF2AK2 | 1.40825552 |
| 30 | NME2 | 1.36693073 |
| 31 | FES | 1.36245104 |
| 32 | MAP3K12 | 1.31802761 |
| 33 | INSRR | 1.31496496 |
| 34 | JAK1 | 1.28843117 |
| 35 | MST4 | 1.28429301 |
| 36 | DAPK2 | 1.27284287 |
| 37 | BMPR2 | 1.25730619 |
| 38 | MATK | 1.25392351 |
| 39 | YES1 | 1.25220518 |
| 40 | PINK1 | 1.22337355 |
| 41 | NEK9 | 1.20960461 |
| 42 | CSF1R | 1.20300596 |
| 43 | BMPR1B | 1.17745005 |
| 44 | TESK2 | 1.17682765 |
| 45 | IRAK2 | 1.13600947 |
| 46 | GRK6 | 1.12513011 |
| 47 | BCKDK | 1.11469199 |
| 48 | HCK | 1.08694242 |
| 49 | WNK3 | 1.08266103 |
| 50 | IRAK1 | 1.07957509 |
| 51 | LCK | 1.05715102 |
| 52 | STK4 | 1.04985316 |
| 53 | ITK | 1.04201192 |
| 54 | GRK7 | 1.01386461 |
| 55 | MAP2K6 | 0.96980043 |
| 56 | ZAK | 0.96962054 |
| 57 | EPHB1 | 0.96792520 |
| 58 | TGFBR1 | 0.95141007 |
| 59 | MAPK13 | 0.93531929 |
| 60 | STK10 | 0.91939658 |
| 61 | PIM1 | 0.91748701 |
| 62 | TRPM7 | 0.89749435 |
| 63 | ADRBK2 | 0.87766232 |
| 64 | PLK4 | 0.85513056 |
| 65 | CHUK | 0.84689293 |
| 66 | OXSR1 | 0.83474714 |
| 67 | VRK1 | 0.81476267 |
| 68 | EIF2AK3 | 0.81237492 |
| 69 | WNK4 | 0.80372413 |
| 70 | FGR | 0.79900522 |
| 71 | ABL2 | 0.77039431 |
| 72 | RPS6KA4 | 0.76493861 |
| 73 | SRPK1 | 0.76134977 |
| 74 | PRKCD | 0.76036046 |
| 75 | PDK2 | 0.74852597 |
| 76 | EIF2AK1 | 0.74661292 |
| 77 | ADRBK1 | 0.74038745 |
| 78 | ERN1 | 0.73801444 |
| 79 | MKNK1 | 0.69139793 |
| 80 | TIE1 | 0.68708007 |
| 81 | TGFBR2 | 0.67766732 |
| 82 | ERBB3 | 0.66277112 |
| 83 | SIK3 | 0.62843923 |
| 84 | MAP3K13 | 0.62766793 |
| 85 | CDK8 | 0.61715800 |
| 86 | TNIK | 0.59220063 |
| 87 | TLK1 | 0.58732627 |
| 88 | PRKCQ | 0.57338346 |
| 89 | MAP2K3 | 0.54866250 |
| 90 | MOS | 0.53751808 |
| 91 | ABL1 | 0.53056914 |
| 92 | PDK1 | 0.52688949 |
| 93 | RPS6KA6 | 0.52425878 |
| 94 | JAK2 | 0.51984196 |
| 95 | NUAK1 | 0.51870366 |
| 96 | ATR | 0.49217578 |
| 97 | RPS6KC1 | 0.48168887 |
| 98 | RPS6KL1 | 0.48168887 |
| 99 | MAPKAPK5 | 0.46856368 |
| 100 | MAP3K3 | 0.45106950 |
| 101 | RPS6KA5 | 0.44718313 |
| 102 | IGF1R | 0.43696690 |
| 103 | MKNK2 | 0.43142551 |
| 104 | KDR | 0.42547283 |
| 105 | CASK | 0.41123553 |
| 106 | MAPK7 | 0.40457057 |
| 107 | GRK1 | 0.38395074 |
| 108 | ARAF | 0.37799172 |
| 109 | MAPK4 | 0.37724545 |
| 110 | MAPKAPK2 | 0.37361534 |
| 111 | FLT3 | 0.37126441 |
| 112 | PTK2B | 0.35328986 |
| 113 | PKN1 | 0.35110502 |
| 114 | BMX | 0.34114413 |
| 115 | MAPK12 | 0.33222962 |
| 116 | TNK2 | 0.32343933 |
| 117 | PRKCE | 0.32014623 |
| 118 | NEK6 | 0.31244665 |
| 119 | STK11 | 0.30870197 |
| 120 | MAP3K4 | 0.30313901 |
| 121 | MUSK | 0.29773634 |
| 122 | SIK2 | 0.28101937 |
| 123 | MAP3K5 | 0.27536191 |
| 124 | CDK19 | 0.26817498 |
| 125 | CSNK2A1 | 0.25925240 |
| 126 | CAMKK1 | 0.25743498 |
| 127 | MARK3 | 0.25727682 |
| 128 | FYN | 0.25451180 |
| 129 | EPHA3 | 0.25282994 |
| 130 | BUB1 | 0.24912294 |
| 131 | MAP3K11 | 0.24665640 |
| 132 | PIK3CG | 0.24381715 |
| 133 | EGFR | 0.23335355 |
| 134 | PLK2 | 0.21992927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.99473236 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96458977 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67602168 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.65113681 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44965419 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28175293 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.21067383 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.20536191 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14141114 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.13395574 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.12939488 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04407934 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01063422 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99818904 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.98328730 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97879451 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.97777802 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.95156514 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94726964 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.90286819 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83125557 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.78947161 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.76239326 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69470924 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69291738 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61473655 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60542648 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.58334673 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57970629 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55335950 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.54859720 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41519573 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37465800 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.32494270 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.31633099 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31219182 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30543438 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29554143 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28947027 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24361409 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.22638711 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 1.20748326 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.19986387 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15815633 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15307085 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.14911983 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.14020517 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08583107 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07502145 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07301668 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04607580 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00133570 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00072314 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99173131 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.97990487 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95824653 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.92903823 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.90900153 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90778367 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88933962 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.87628287 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87489230 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86744152 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85138095 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84762840 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84134102 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83488617 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83099476 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76412798 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71604291 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70792443 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69528137 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69417734 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69154646 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.68809185 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67488154 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63253090 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62776130 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62278285 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62013956 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61627675 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60931884 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60338767 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59784245 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59617147 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58554721 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55126927 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50127978 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49905813 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48826749 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47065454 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46816257 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46639115 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.42675840 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42210439 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40736092 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.39698893 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39160064 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38541011 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37966601 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37786523 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36773147 |
| 103 | Spliceosome_Homo sapiens_hsa03040 | 0.35687414 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34057371 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.32386807 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31080959 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30965999 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30642095 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30420875 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29832900 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29280599 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27952645 |
| 113 | Morphine addiction_Homo sapiens_hsa05032 | 0.27824000 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.27564486 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.27404680 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26831499 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23973155 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23659424 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.23519471 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22454746 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22342145 |
| 122 | RNA degradation_Homo sapiens_hsa03018 | 0.21863771 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19909053 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19468320 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18208322 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.17210064 |
| 127 | Taste transduction_Homo sapiens_hsa04742 | 0.16279233 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.15322794 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13488312 |

